Context
In 2024, two-year-old Lily Stock was diagnosed with metachromatic leukodystrophy (MLD), a rare and progressive disease. Libmeldy, a lifesaving gene therapy available through the NHS, must be administered before symptoms develop but is too late for Lily due to lack of early diagnosis.
Question
In 2024, two-year-old Lily Stock was diagnosed with metachromatic leukodystrophy (MLD), a rare and progressive disease that will slowly take her away. Libmeldy, a lifesaving gene therapy available through the NHS, must be administered before symptoms develop but is too late for Lily due to lack of early diagnosis. Emily and Sean, Lily’s parents, are campaigning for MLD screening to be added to the heel-prick test on newborns so that MLD can be identified early and treated effectively, preventing families from going through this devastating experience. Will the Minister and her officials look into adding MLD screening to the heel-prick test, and will she and the Secretary of State join me to meet Lily’s family and hear their story at first hand?
Answer from The Parliamentary Under-Secretary of State for Health and Social Care (Ashley Dalton)
I thank my hon. Friend for raising this matter. Lily’s story really lays bare the heartbreak that rare diseases can bring and the vital role that early diagnosis can play. I am happy to meet my hon. Friend and Lily’s family. May I suggest that we meet when the UK National Screening Committee has completed its review, so that the Government have received advice on this important matter? We can then discuss that advice together.
Not addressed: Commitment to add MLD screening to the heel-prick test without specific details or timeline
Was this summary accurate? Tell us
How accurate was this summary? (1 = poor, 5 = spot on)